English
Français
>>
>>
News
Agenda
Subscribe to our newsletter
Annual Shareholders Meeting of May 20, 2015 : Access to the voting results
To contact us
BECOME A PARTNER
BECOME A SHAREHOLDER
NEWS >
Update on ReLive, Livatag® international phase III clinical trial in HCC - 50% patients randomized - Opdatering om ReLive, det internationale kliniske fase III-studie med Livatag® til behandling af leverkræft 50% patienter randomiseret
Meetings with the financial community during the 2nd semester of 2015 - Møder med finansverdenen i 2. halvår 2015
AGENDA >
Analyst Meeting at the Company's Headquarters
September 16, 2015
InvestorDagen (Radisson Blu Scandinavia Hotel - Copenhagen, Denmark)
September 22, 2015
